- Home
- DYN vs AEO Comparison
DYN vs AEO Comparison
Compare DYN & AEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- AEO
- Stock Information
- Founded
- DYN 1984
- AEO 1977
- Country
- DYN United States
- AEO United States
- Employees
- DYN N/A
- AEO N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- AEO Clothing/Shoe/Accessory Stores
- Sector
- DYN Health Care
- AEO Consumer Discretionary
- Exchange
- DYN Nasdaq
- AEO Nasdaq
- Market Cap
- DYN 2.6B
- AEO 2.3B
- IPO Year
- DYN 2020
- AEO 1994
- Fundamental
- Price
- DYN $9.23
- AEO $12.22
- Analyst Decision
- DYN Strong Buy
- AEO Hold
- Analyst Count
- DYN 12
- AEO 11
- Target Price
- DYN $47.73
- AEO $16.60
- AVG Volume (30 Days)
- DYN 1.8M
- AEO 7.3M
- Earning Date
- DYN 05-01-2025
- AEO 03-12-2025
- Dividend Yield
- DYN N/A
- AEO 4.09%
- EPS Growth
- DYN N/A
- AEO 94.44
- EPS
- DYN N/A
- AEO 1.68
- Revenue
- DYN N/A
- AEO $5,328,652,000.00
- Revenue This Year
- DYN N/A
- AEO $4.30
- Revenue Next Year
- DYN N/A
- AEO $3.89
- P/E Ratio
- DYN N/A
- AEO $7.27
- Revenue Growth
- DYN N/A
- AEO 1.27
- 52 Week Low
- DYN $9.17
- AEO $10.74
- 52 Week High
- DYN $47.45
- AEO $25.95
- Technical
- Relative Strength Index (RSI)
- DYN 26.62
- AEO 46.99
- Support Level
- DYN $10.72
- AEO $11.22
- Resistance Level
- DYN $12.00
- AEO $13.06
- Average True Range (ATR)
- DYN 0.76
- AEO 0.57
- MACD
- DYN -0.11
- AEO 0.14
- Stochastic Oscillator
- DYN 1.52
- AEO 63.79
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About AEO American Eagle Outfitters Inc.
American Eagle Outfitters Inc is a specialty retailer. The company is engaged in the retail of apparel and accessories with company stores in the United States, Canada, Mexico, and Hong Kong. The Company leases all store premises, regional distribution facilities, some of its office space, and certain information technology and office equipment. American Eagle also has its online business. It operates in two segments: American Eagle and Aerie. The majority of its revenue comes from its primary brand, American Eagle, which offers an assortment of specialty apparel, accessories, and personal care products for women and men. Geographically, it generates the vast majority of its revenue from the United States.